XL184 80mg Pill - orange capsule/oblong
Generic Name: cabozantinib
Pill with imprint XL184 80mg is Orange, Capsule/Oblong and has been identified as Cometriq 80 mg. It is supplied by Exelixis, Inc.
Cometriq is used in the treatment of Thyroid Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Cometriq 80 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for XL184 80mg
Cometriq
- Generic Name
- cabozantinib
- Imprint
- XL184 80mg
- Strength
- 80 mg
- Color
- Orange
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Exelixis, Inc.
- National Drug Code (NDC)
More about Cometriq (cabozantinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
